Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
E-Mail HOUSTON-(Feb. 1, 2021) - Houston Methodist researchers have developed a mathematical model to predict how specific cancers will respond to immunotherapy treatments, thus enhancing chances for successful treatments from a wide variety of cancer-immunotherapy drug combinations. The results were published last month in Nature Biomedical Engineering in collaboration with researchers at MD Anderson Cancer Center. Immunotherapy activates patients' immune systems to recognize and attack their cancers, leading to higher, more targeted kill rates and fewer side effects than chemotherapy, rad...